Literature DB >> 33992859

Innate immunity and HBV persistence.

Carolina Chiale1, Anthony M Marchese1, Michael D Robek2.   

Abstract

Hepatitis B virus (HBV) causes chronic infections that are associated with immune dysfunction. Though T cell impairment is perhaps the most prominent immune change contributing to viral persistence, HBV interaction with the innate immune system is also likely key, as the lack of effective innate immunity has functional consequences that promote chronic infection. In addition to an intrinsic ability to fight viral infections, the innate immune system also impacts T cell responses and other adaptive immune mechanisms critical for HBV control. Therefore, it is essential to understand the relationships between HBV and innate immunity, as these interactions may be useful immunotherapeutic targets to manage the infection.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33992859      PMCID: PMC8319108          DOI: 10.1016/j.coviro.2021.04.003

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.121


  81 in total

1.  Characteristics of Impaired Dendritic Cell Function in Patients With Hepatitis B Virus Infection.

Authors:  Atsushi Yonejima; Eishiro Mizukoshi; Toshikatsu Tamai; Hidetoshi Nakagawa; Masaaki Kitahara; Tatsuya Yamashita; Kuniaki Arai; Takeshi Terashima; Noriho Iida; Kazumi Fushimi; Hikari Okada; Taro Yamashita; Yoshio Sakai; Masao Honda; Shuichi Kaneko
Journal:  Hepatology       Date:  2019-05-24       Impact factor: 17.425

2.  Hepatitis B Virus Particles Activate Toll-Like Receptor 2 Signaling Initially Upon Infection of Primary Human Hepatocytes.

Authors:  Zhenhua Zhang; Martin Trippler; Catherine I Real; Melanie Werner; Xufeng Luo; Stefan Schefczyk; Thekla Kemper; Olympia E Anastasiou; Yvonne Ladiges; Juergen Treckmann; Andreas Paul; Hideo A Baba; Lena Allweiss; Maura Dandri; Guido Gerken; Heiner Wedemeyer; Joerg F Schlaak; Mengji Lu; Ruth Broering
Journal:  Hepatology       Date:  2020-07-11       Impact factor: 17.425

3.  Safety, pharmacokinetics and pharmacodynamics of selgantolimod, an oral Toll-like receptor 8 agonist: a Phase Ia study in healthy subjects.

Authors:  Maribel Reyes; Justin D Lutz; Audrey H Lau; Anuj Gaggar; Ethan P Grant; Adarsh Joshi; Richard L Mackman; John Ling; Susanna K Tan; Natarajan Ayithan; Stephane Daffis; Jacky Woo; Peiwen Wu; Tina Lam; Simon P Fletcher; Shyamasundaran Kottilil; Bhawna Poonia; Edward J Gane; Anita Mathias; Polina German
Journal:  Antivir Ther       Date:  2020

4.  Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.

Authors:  Keith B Gorden; Kevin S Gorski; Sheila J Gibson; Ross M Kedl; William C Kieper; Xiaohong Qiu; Mark A Tomai; Sefik S Alkan; John P Vasilakos
Journal:  J Immunol       Date:  2005-02-01       Impact factor: 5.422

5.  Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B.

Authors:  Stephan Menne; Daniel B Tumas; Katherine H Liu; Linta Thampi; Dalal AlDeghaither; Betty H Baldwin; Christine A Bellezza; Paul J Cote; Jim Zheng; Randall Halcomb; Abigail Fosdick; Simon P Fletcher; Stephane Daffis; Li Li; Peng Yue; Grushenka H I Wolfgang; Bud C Tennant
Journal:  J Hepatol       Date:  2015-01-02       Impact factor: 25.083

6.  Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B.

Authors:  Renate G van der Molen; Dave Sprengers; Rekha S Binda; Esther C de Jong; Hubert G M Niesters; Johannes G Kusters; Jaap Kwekkeboom; Harry L A Janssen
Journal:  Hepatology       Date:  2004-09       Impact factor: 17.425

Review 7.  Mucosal-associated invariant T cells and disease.

Authors:  Amine Toubal; Isabelle Nel; Sophie Lotersztajn; Agnès Lehuen
Journal:  Nat Rev Immunol       Date:  2019-10       Impact factor: 53.106

8.  Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection.

Authors:  Dimitra Peppa; Lorenzo Micco; Alia Javaid; Patrick T F Kennedy; Anna Schurich; Claire Dunn; Celeste Pallant; Gidon Ellis; Pooja Khanna; Geoffrey Dusheiko; Richard J Gilson; Mala K Maini
Journal:  PLoS Pathog       Date:  2010-12-16       Impact factor: 6.823

9.  Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells.

Authors:  Isabelle E Vincent; Claudia Zannetti; Julie Lucifora; Helene Norder; Ulrike Protzer; Pierre Hainaut; Fabien Zoulim; Massimo Tommasino; Christian Trépo; Uzma Hasan; Isabelle Chemin
Journal:  PLoS One       Date:  2011-10-25       Impact factor: 3.240

10.  Suppression of hepatitis B virus through therapeutic activation of RIG-I and IRF3 signaling in hepatocytes.

Authors:  Sooyoung Lee; Ashish Goyal; Alan S Perelson; Yuji Ishida; Takeshi Saito; Michael Gale
Journal:  iScience       Date:  2021-01-04
View more
  4 in total

1.  Toll-Like Receptor 7 Agonist RG7854 Mediates Therapeutic Efficacy and Seroconversion in Woodchucks With Chronic Hepatitis B.

Authors:  Steffen Wildum; Kyle E Korolowicz; Manasa Suresh; Guido Steiner; Lue Dai; Bin Li; Changsuek Yon; Maria Cristina De Vera Mudry; Franziska Regenass-Lechner; Xu Huang; Xupeng Hong; Marta G Murreddu; Bhaskar V Kallakury; John A T Young; Stephan Menne
Journal:  Front Immunol       Date:  2022-05-23       Impact factor: 8.786

2.  Agonistic Activation of Cytosolic DNA Sensing Receptors in Woodchuck Hepatocyte Cultures and Liver for Inducing Antiviral Effects.

Authors:  Manasa Suresh; Bin Li; Xu Huang; Kyle E Korolowicz; Marta G Murreddu; Severin O Gudima; Stephan Menne
Journal:  Front Immunol       Date:  2021-10-04       Impact factor: 7.561

Review 3.  Regulation of Pattern-Recognition Receptor Signaling by HBX During Hepatitis B Virus Infection.

Authors:  Hongjuan You; Suping Qin; Fulong Zhang; Wei Hu; Xiaocui Li; Dongsheng Liu; Fanyun Kong; Xiucheng Pan; Kuiyang Zheng; Renxian Tang
Journal:  Front Immunol       Date:  2022-02-17       Impact factor: 7.561

Review 4.  Interaction between the Hepatitis B Virus and Cellular FLIP Variants in Viral Replication and the Innate Immune System.

Authors:  Ah Ram Lee; Yong Kwang Park; Mehrangiz Dezhbord; Kyun-Hwan Kim
Journal:  Viruses       Date:  2022-02-11       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.